Ala. Admin. Code r. 540-X-8-.11 - Prescriptions And Medication Orders By Certified Registered Nurse Practitioners

(1) Certified registered nurse practitioners engaged in collaborative practice with physicians may be granted prescriptive authority upon submission of evidence of completion of an academic course in pharmacology or evidence of integration of pharmacology theory and clinical application in the certified registered nurse practitioner curriculum.
(2) Certified registered nurse practitioners practicing under protocols approved in the manner prescribed by Code of Ala. 1975, §§ 34-21-80 et seq. may prescribe legend drugs to their patients, subject to the following conditions:
(a) The drug shall be included in the formulary recommended by the Joint Committee and adopted by the Board of Nursing and the State Board of Medical Examiners.
(b) The drug type, dosage, quantity prescribed, and number of refills shall be authorized in an approved protocol signed by the collaborating physician and the certified registered nurse practitioner. This requirement may be met if written prescriptions adhere to the standard recommended dosages of legend drugs as identified in the Physicians Desk Reference or Product Information Insert, and do not:
1. Exceed the recommended treatment regimen periods.
2. Include United States Food and Drug Administration (FDA) non-approved supplements, drug products, medication, and off label medications.
(c) Drugs and medications that do not have FDA approval may be prescribed through protocol registration in a United States Institutional Review Board or Expanded Access authorized clinical trial.
(d) "Off label" use or prescription of FDA-approved medications for uses other than that indicated by the FDA is permitted when such practices are:
1. Within the current standard of care for treatment of disease or condition.
2. Supported by evidence-based research.
3. Approved by the collaborating physician and entered into the patient record.
(3) A certified registered nurse practitioner may not initiate a call-in prescription in the name of a collaborating physician for any drug, whether legend or controlled substance, which the certified registered nurse practitioner is not authorized to prescribe under the protocol signed by the collaborating physician and certified registered nurse practitioner and approved under this section unless the drug is specifically ordered for the patient by the physician, either in writing or by a verbal order which has been transcribed in writing, and which has been signed by the physician within seven working days or as otherwise specified by the Board of Nursing and the Board of Medical Examiners.
(4) A written prescription for any drug that the certified registered nurse practitioner is authorized to prescribe may be called in to a pharmacy, provided the prescription is entered into the patient's record and signed by the certified registered nurse practitioner.
(5) The certified registered nurse practitioner in collaborative practice with prescriptive privileges shall not engage in prescribing for:
(a) Self.
(b) Immediate family members.
(c) Individuals who are not patients of the practice, except in cases, where a certified registered nurse practitioner is prescribing for the sexual partner(s) of a patient in accordance with an Expedited Partner Therapy (EPT) protocol for the prevention of transmission and spread of sexually transmitted disease(s).
(6) The certified registered nurse practitioner who is in collaborative practice and has prescriptive privileges may receive and sign for samples of legend drugs that are authorized in the approved formulary for the collaborative practice, provided the certified registered nurse practitioner complies with all applicable state and federal laws and regulations.
(7) When prescribing legend drugs a certified registered nurse practitioner shall use a prescription form which includes all of the following:
(a) The name, medical practice site address and telephone number of the collaborating physician or covering physician;
(b) The name of the certified registered nurse practitioner;
(c) The medical practice site address and telephone number of the certified registered nurse practitioner if different from that of the collaborating physician;
(d) The certified registered nurse practitioner's registered nurse license number assigned by the Board of Nursing;
(e) The words "Product Selection Permitted" printed on one side of the prescription form directly beneath a signature line;
(f) The words "Dispense as written" printed on one side of the prescription form directly beneath a signature line.
(g) The date that the prescription is issued to the patient.

Notes

Ala. Admin. Code r. 540-X-8-.11
New Rule: Filed June 20, 1996; effective July 26, 1996. Amended: Filed August 25, 2003; effective September 29, 2003. Amended by Alabama Administrative Monthly Volume XXXIII, Issue No. 10, July 31, 2015, eff. 8/6/2015. Amended by Alabama Administrative Monthly Volume XXXV, Issue No. 01, October 30, 2016, eff. 12/4/2016. Amended by Alabama Administrative Monthly Volume XXXVII, Issue No. 09, June 28, 2019, eff. 8/3/2019. Amended by Alabama Administrative Monthly Volume XXXIX, Issue No. 07, April 30, 2021, eff. 6/14/2021.

Author: Alabama Board of Medical Examiners

Statutory Authority: Code of Ala. 1975, §§ 34-21-86, 34-24-53.

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.


No prior version found.